All Comments by Vincent Marchesi
- Webinar: Pathogenic Protein Spread? Let’s Think Again
- Webinar: Can ‘Cellular Phase’ Unite Disparate Data on Alzheimer’s Pathogenesis?
- No REST for Weary Neurons: Protective Factor Stems Cognitive Decline
- NIH Funds Prevention Trials and Translational Studies
- Combination Drug Trials: Time to Open a New Front in AD?
- A multimodal RAGE-specific inhibitor reduces amyloid β-mediated brain disorder in a mouse model of Alzheimer disease.
- Contrast-enhanced magnetic resonance microangiography reveals remodeling of the cerebral microvasculature in transgenic ArcAβ mice.
- Testing the right target and right drug at the right stage.
- Intraneuronal APP, not free Aβ peptides in 3xTg-AD mice: implications for tau versus Aβ-mediated Alzheimer neurodegeneration.
- Committee Shoots Down Florbetapir, Raising Bar for Field at Large
- What Do Clinicians Say? Peers Welcome Revised Criteria
- DIAN Dispatch from Hawaii: Glimpse at Data, Push for Trials
- Inside Out—Plaques May Have Intracellular Origin
- Together at Last, Top Five Biomarkers Model Stages of AD
- ADNI: One-year Data Narrow Field of MRI, FDG-PET Approaches